Emcure plea to direct NPPA to review HIV drugs price junked by DoP Farhat Nasim3 Feb 2020 1:41 PM ISTNew Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
Launching product without Approval: DOP rejects Biocon Plea against NPPA action Meghna A Singhania24 Feb 2019 11:25 AM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
Hetero launches generic Lapatinib under the brand name HERTAB in India Farhat Nasim12 Jan 2019 12:14 PM ISTHERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose...
Hetero Labs Limited acquires Tarbis Farma in Spain Medical Dialogues Bureau3 Jan 2019 9:15 AM ISTThe acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio,...
Hetero gets DCGI nod to market anti-retroviral FDC tablets Ruby Khatun Khatun17 Nov 2017 10:45 AM ISTNew Delhi: Drug firm Hetero said it has received the Drug Controller General of India's approval to launch generic fixed-dose combination...
